Cost Per Patient And Budget Impact Prediction Of Denosumab Versus Zoledronic Acid In Prevention Of Skeletal-Related Events...
Upcoming SlideShare
Loading in …5
×

Cost Per Patient And Budget Impact Prediction Of Denosumab Versus Zoledronic Acid In Prevention Of Skeletal-Related Events (SREs) In Patients With Bone Metastases From Solid Tumours In Portugal And Sweden

448 views

Published on

Lothgren Mickael, Cristino Joaquim, Lundkvist Jonas, Vrouchou Polina, Bracco Andrea, Pereira João Cost Per Patient And Budget Impact Prediction Of Denosumab Versus Zoledronic Acid In Prevention Of Skeletal-Related Events (SREs) In Patients With Bone Metastases From Solid Tumours In Portugal And Sweden

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
448
On SlideShare
0
From Embeds
0
Number of Embeds
3
Actions
Shares
0
Downloads
8
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

×